NASDAQ: BOLD
Boundless Bio Inc Stock Ownership - Who owns Boundless Bio?

Insider buying vs selling

Have Boundless Bio Inc insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when BOLD insiders and whales buy or sell their stock.

BOLD Shareholders

What type of owners hold Boundless Bio Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Fmr LLC11.98%2,684,022$3.06MInstitution
Citadel Advisors LLC6.04%1,353,904$1.54MInstitution
Arch Venture Fund IX LP5.27%1,181,766$1.35MInsider
Kristina Burow5.27%1,181,766$1.35MInsider
Keith Crandell5.27%1,181,766$1.35MInsider
Stonepine Capital Management LLC3.17%710,071$809.48kInstitution
Sectoral Asset Management Inc3.03%678,574$773.57kInstitution
Vanguard Group Inc2.96%662,757$755.54kInstitution
Jonathan E. Lim2.92%653,479$744.97kInsider
Wellington Biomedical Innovation Master Investors Cayman I LP2.48%556,233$634.11kInsider

1 of 3

BOLD vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
BOLD39.19%23.80%
SNTI17.94%82.06%
LONA33.55%66.45%Net BuyingNet Buying
XCUR0.23%99.77%Net SellingNet Selling
IGC5.20%21.83%

Boundless Bio Stock Ownership FAQ

Who owns Boundless Bio?

Boundless Bio (NASDAQ: BOLD) is owned by 39.19% institutional shareholders, 23.80% Boundless Bio insiders, and 37.01% retail investors. Arch Venture Fund IX LP is the largest individual Boundless Bio shareholder, owning 1.18M shares representing 5.27% of the company. Arch Venture Fund IX LP's Boundless Bio shares are currently valued at $1.36M.

If you're new to stock investing, here's how to buy Boundless Bio stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.